Melola Discovery

← Melola Discovery

Journal SINTA 1

Artificial Intelligence Based Deep Bayesian Neural Network (DBNN) Toward Personalized Treatment of Leukemia with Stem Cells

Journal of Robotics and Control (JRC) · Vol. 3 No. 6 (2023) · pp. 809–816

DOI
10.18196/jrc.v3i6.16200
ISSN
2715-5072, 2715-5056
Published
2023-01-01
Publisher
Universitas Muhammadiyah Yogyakarta
Language
eng

Abstract

The dynamic development of computer and software technology in recent years was accompanied by the expansion and widespread implementation of artificial intelligence (AI) based methods in many aspects of human life. A prominent field where rapid progress was observed are high‐throughput methods in biology that generate big amounts of data that need to be processed and analyzed. Therefore, AI methods are more and more applied in the biomedical field, among others for RNA‐protein binding sites prediction, DNA sequence function prediction, protein‐protein interaction prediction, or biomedical image classification. Stem cells are widely used in biomedical research, e.g., leukemia or other disease studies. Our proposed approach of Deep Bayesian Neural Network (DBNN) for the personalized treatment of leukemia cancer has shown a significant tested accuracy for the model. DBNNs used in this study was able to classify images with accuracy exceeding 98.73%. This study depicts that the DBNN can classify cell cultures only based on unstained light microscope images which allow their further use. Therefore, building a bayesian‐based model to great help during commercial cell culturing, and possibly a first step in the process of creating an automated/semiautomated neural network‐based model for classification of good and bad quality cultures when images of such will be available.

Keywords

Collaboration network of the authors

5 authors · 10 co-authorship links · 3 across different organisations

Hover or tap a name to highlight its co-authors. Double-click to open the author's page.

  • University of Baghdad
  • Al-Mustaqbal University
  • Affiliation unknown
  • Different organisations
  • Same organisation
  • Affiliation unknown
  • Thicker line = more joint articles · bigger circle = more articles
Show as table
Co-authorOrganisationJoint articles
Hassan Muwafaq GheniAl-Mustaqbal University1
Geehan Sabah HassanUniversity of Baghdad1
Noora Jamal AliAffiliation unknown1
Farah Jasim MohammedUniversity of Baghdad1

Affiliations come from OpenAlex; journal OAI-PMH metadata carries none. Authors without an OpenAlex ID are matched by name, which can merge or split people.

Metadata source: OAI-PMH (metadata jurnal) https://journal.umy.ac.id/index.php/jrc/oai, first harvested 9 Nov 2026, last seen 16 Nov 2026.
Original metadata (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Artificial Intelligence Based Deep Bayesian Neural Network (DBNN) Toward Personalized Treatment of Leukemia with Stem Cells</dc:title>
	<dc:creator>Khazaal Abdulsahib, Asma</dc:creator>
	<dc:subject xml:lang="en-US">Leukemia</dc:subject>
	<dc:subject xml:lang="en-US">Deep Bayesian Neural Network (DBNN)</dc:subject>
	<dc:subject xml:lang="en-US">Leukemia stem cells (LSC)</dc:subject>
	<dc:subject xml:lang="en-US">Convolution neural network (CNN)</dc:subject>
	<dc:subject xml:lang="en-US">Artificial intelligence (AI)</dc:subject>
	<dc:subject xml:lang="en-US">Personalized treatment</dc:subject>
	<dc:description xml:lang="en-US">The dynamic development of computer and software technology in recent years was accompanied by the expansion and widespread implementation of artificial intelligence (AI) based methods in many aspects of human life. A prominent field where rapid progress was observed are high‐throughput methods in biology that generate big amounts of data that need to be processed and analyzed. Therefore, AI methods are more and more applied in the biomedical field, among others for RNA‐protein binding sites prediction, DNA sequence function prediction, protein‐protein interaction prediction, or biomedical image classification. Stem cells are widely used in biomedical research, e.g., leukemia or other disease studies. Our proposed approach of Deep Bayesian Neural Network (DBNN) for the personalized treatment of leukemia cancer has shown a significant tested accuracy for the model. DBNNs used in this study was able to classify images with accuracy exceeding 98.73%. This study depicts that the DBNN can classify cell cultures only based on unstained light microscope images which allow their further use. Therefore, building a bayesian‐based model to great help during commercial cell culturing, and possibly a first step in the process of creating an automated/semiautomated neural network‐based model for classification of good and bad quality cultures when images of such will be available.</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Muhammadiyah Yogyakarta</dc:publisher>
	<dc:date>2023-01-01</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.umy.ac.id/index.php/jrc/article/view/16200</dc:identifier>
	<dc:identifier>10.18196/jrc.v3i6.16200</dc:identifier>
	<dc:source xml:lang="en-US">Journal of Robotics and Control (JRC); Vol. 3 No. 6 (2022): November; 809-816</dc:source>
	<dc:source>2715-5072</dc:source>
	<dc:source>2715-5056</dc:source>
	<dc:source>10.18196/jrc.v3i6</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.umy.ac.id/index.php/jrc/article/view/16200/8012</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2023 Asma Khazaal Abdulsahib</dc:rights>
</oai_dc:dc>